Page last updated: 2024-09-03

y 27632 and lipid a

y 27632 has been researched along with lipid a in 1 studies

Compound Research Comparison

Studies (y 27632)	Trials (y 27632)	Recent Studies (post-2010) (y 27632)	Studies (lipid a)	Trials (lipid a)	Recent Studies (post-2010) (lipid a)
1,924	3	891	3,901	125	1,143

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ehrhard, M; Fritzsching, B; Frommhold, D; Koch, L; Poeschl, J; Ruef, P	1

Other Studies

1 other study(ies) available for y 27632 and lipid a

Article	Year
Lipid A decreases human erythrocytes deformability by increasing intracellular Ca(2+): effects of verapamil, staurosporine and the rho-kinase inhibitor Y-27632. Clinical hemorheology and microcirculation, 2011, Volume: 49, Issue:1-4 Topics: Adult; Amides; Calcium Channel Blockers; Calcium Signaling; Depression, Chemical; Drug Interactions; Erythrocyte Deformability; Escherichia coli; Humans; In Vitro Techniques; Lipid A; Male; Protein Kinase Inhibitors; Pyridines; rho-Associated Kinases; Shear Strength; Staurosporine; Verapamil	2011

Article

Year

Lipid A decreases human erythrocytes deformability by increasing intracellular Ca(2+): effects of verapamil, staurosporine and the rho-kinase inhibitor Y-27632.

Clinical hemorheology and microcirculation, 2011, Volume: 49, Issue:1-4

Topics: Adult; Amides; Calcium Channel Blockers; Calcium Signaling; Depression, Chemical; Drug Interactions; Erythrocyte Deformability; Escherichia coli; Humans; In Vitro Techniques; Lipid A; Male; Protein Kinase Inhibitors; Pyridines; rho-Associated Kinases; Shear Strength; Staurosporine; Verapamil

2011